Perry Andrew 4
4 · G1 Therapeutics, Inc. · Filed Aug 17, 2021
Insider Transaction Report
Form 4
Perry Andrew
Chief Commercial Officer
Transactions
- Award
Stock Options (Right to buy)
2021-08-16+300,000→ 300,000 totalExercise: $14.03Exp: 2031-08-16→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% of the shares on July 28, 2022, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each applicable vesting date.